1Okazaki T,Honjo T.The PD-1-PD-L pathway in immunological tolerance[J].Trends Immunol,2006,27(4):195-201.
2Greenwald RJ,Freeman GJ,Sharpe AH.The B7 family revisited[J].Annu Rev Immunol.2005,23:515-548.
3Parry RV,Chemnitz JM,Frauwirth KA,et al.CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms[J].Mol Cell Biol,2005,25(21):9543-9553.
4Latchman Y,Wood CR,Chernova T,et al.PD-L2 is a second ligand for PD-1 and inhibits T cell activation[J].Nat Immunol,2001,2(3):261-268.
5Brown JA,Dorfman DM,Ma FR,et al.Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production[J].J Immunol,2003,170(3):1257-1266.
6Chen L.Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity[J].Nat Rev Immunol,2004,4(5):336-347.
7Freeman GJ,Long AJ,Iwai Y,et al.Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation[J].J Exp Med,2000,192(7):1027-1034.
8Eppihimer MJ,Gunn J,Freeman GJ,et al.Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells[J].Microcirculation,2002,9(2):133-145.
9Muhlbauer M,Fleck M,Schutz C,et al.PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis[J].J Hepatol,2006,45(4):520-528.
10Koga N,Suzuki J,Kosuge H,et al.Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts[J].Arterioscler Thromb Vasc Biol,2004,24(11):2057-2062.
2GOLDEN-MASON L,KLARQUIST J,WAHED A S,et al.Programmed death-1expression is increased on im-munocyte in chronic hepatitis C virus and predicts failure to antiviral therapy:race-dependent differences. J Immunol . 2008
3MARIANNE M,MARTINIC,MATTHIAS G,et al.Novel strategies to eliminate persistent viral infections. Journal of Autoimmune Diseases . 2008
4SMHENSON,RMACAULAY,SKIANI-ALIKHAN,et al.The use of the inhibitory receptors for modulating the im-mune responses. J Immunology . 2008
5ITO T,UENO T,CLARKSON MR,et al.Anslysis of the of negative T cell costimulatory pathways in CD4+and CD8+T cell-mediated alloimmune responses in vivo. J Immunal . 2005
6NAKAE S,SUTO H,LIKARA M,et al.Mast cell en-hance T cell activation:important of mast cell costimula-tory molecules and secreted TNF. J Immunal . 2006
7ALEXANDER EVANS,ANTONIORIVA,HELENCOO-KSLRY,et al.Programmed death1expression during antiviral treatment of hepatitis b:Impact of hepatitis b e-antigen seroconversion. Journal of Hepatology . 2008
8Barber,DL,Wherry,EJ,Masopust,D.Restoring function in exhausted CD8 T cells during chronic viral infection. Nature . 2006
9Barber,DL,Wherry,EJ,Masopust,D.Restoring function in exhausted CD8 T cells during chronic viral infection. Nature . 2006
10Boni C,Fisicaro P,Valdatta C,et al.Characterization of hepatitis B virus(HBV)-specific T-cell dysfunction in chronic HBVinfection. Journal of Virology . 2007
